This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: P CI HUM LPX RDC

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Cigna (CI - Get Report) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $56 price target. New analyst also placed the company on the US Focus List. Company can continue to grow the business and return capital to shareholders. $56 price target.

Cepheid (CPHD) rated new Hold at Cantor. Valuation call, based on a $40 price target.

Equifax (EFX) rated new Hold at Deutsche Bank. Valuation call, based on a $47 price target.

Humana (HUM - Get Report) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $74 price target. New analyst has a $74 price target.

Louisiana-Pacific (LPX - Get Report) upgraded at BofA/Merrill from Underperform to Buy, Bank of America/Merrill Lynch said. Valuation call, based on a $16 price target.

Louisiana-Pacific downgraded at Deutsche. LPX was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on a $12 price target.

Pandora (P - Get Report) upgraded at Canaccord from Hold to Buy, Canaccord Genuity said. Visibility is improving. $16 price target.

Rowan (RDC - Get Report) rated new Outperform at Credit Suisse. RDC was initiated with an Outperform rating, Credit Suisse said. $50 price target. Company was also placed on the Focus List. Company trades at a discount to its peers.

Vertex Pharmaceuticals (VRTX) rated new Buy at ThinkEquity. $64 price target. Kalydeco should drive near-term growth.

STOCK COMMENTS / EPS CHANGES

Brown Forman (BF.B) numbers raised at UBS. Shares of BF.b now seen reaching $72, UBS said. Estimates also increased on positive outlook. Buy rating.

HJ Heinz (HNZ) numbers reduced at Credit Suisse. HNZ estimates were cut through 2015, Credit Suisse said. Company is seeing lower operating earnings. Neutral rating and new $57 price target.

Joy Global (JOY) numbers lowered at Jefferies. Shares of JOY now seen reaching $50, Jefferies said. Estimates also lowered on poor revenue outlook. Hold rating.

Pandora (P - Get Report) estimates, target raised at Credit Suisse. Shares of P now seen reaching $13, according to Credit Suisse. Estimates also increased, as the company is realizing higher operating leverage. Neutral rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CI $121.63 0.00%
HUM $164.38 0.00%
LPX $16.83 0.00%
P $14.80 0.00%
RDC $21.61 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs